Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
None on record since 2016.
Sits alongside
People who currently share a board or management team with this person.
- Alecia A. DecoudreauxCVS
- Amy Compton-PhillipsCVS
- Anne A. FinucaneCVS
- Brian NewmanCVS
- C. David Brown IICVS
- Douglas H. ShulmanCVS
- Fernando AguirreCVS
- Guy P. SansoneCVS
- Heidi B. CapozziCVS
- James David ClarkCVS
- J. David JoynerCVS
- Jeffrey R. BalserCVS
- John E. GallinaCVS
- J. Scott KirbyCVS
- Larry RobbinsCVS
- Leslie Norwalk VCVS
- Michael F. MahoneyCVS
- Roger N. FarahCVS
- Samrat S. KhichiCVS
- Steven H. NelsonCVS
- Tilak MandadiCVS
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | CVS | Buy | 23,855 | $83.90 | $2.0M |
| Feb 16, 2024 | CVS | Sale | 29,473 | $76.95 | $2.3M |
| Apr 8, 2022 | CVS | Sale | 3,130 | $105.00 | $329K |
| Apr 8, 2022 | CVS | Sale | 4,103 | $105.00 | $431K |
| Apr 8, 2022 | CVS | Sale | 845 | $105.00 | $89K |
| Apr 8, 2022 | CVS | Sale | 3,157 | $105.00 | $331K |
| Apr 8, 2022 | CVS | Sale | 5,719 | $105.00 | $600K |
| Mar 30, 2022 | CVS | Sale | 5,346 | $104.70 | $560K |
| Mar 17, 2022 | CVS | Sale | 1,689 | $106.65 | $180K |
| Mar 17, 2022 | CVS | Sale | 2,935 | $106.65 | $313K |
SEC reporting-owner ID (CIK) 1900910 · all filings on EDGAR